MM-111 Drug Record

  • MM-111 chembl:CHEMBL4297556 Antineoplastic

    Alternate Names:

    MM-111

    Drug Info:

    Drug Class Therapeutic Antibodies
    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antineoplastic agent
    (1 More Sources)

    Publications:

  • MM-111   ERBB3

    Interaction Score: 2.06

    Interaction Types & Directionality:
    antibody (inhibitory)

    Interaction Info:
    Trial Name MM-111
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    MyCancerGenome TdgClinicalTrial

  • MM-111   ERBB2

    Interaction Score: 0.84

    Interaction Types & Directionality:
    antibody (inhibitory)

    Interaction Info:
    combination therapy Paclitaxel + Trastuzumab + MM-111
    Indication/Tumor Type stomach cancer
    Response Type sensitive

    PMIDs:
    None found


    Sources:
    MyCancerGenome TdgClinicalTrial JAX-CKB TTD

  • MyCancerGenome: MM-111

    • Version: 20-Jun-2017

    Alternate Names:
    MM-111 Development Name

    Drug Info:
    Drug Class Therapeutic Antibodies

    Publications:

  • TdgClinicalTrial: MM-111

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class monoclonal antibody
    FDA Approval not approved

    Publications:

  • TTD: MM-111

    • Version: 2020.06.01

    Alternate Names:
    D0Q2KM TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL4297556

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • JAX-CKB: MM-111

    • Version: 27-September-2017

    Alternate Names:

    Drug Info:

    Publications: